These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24182611)

  • 61. [Problems and future directions of functional test for gastrointestinal tract].
    Haruma K; Manabe N; Kusunoki H
    Nihon Shokakibyo Gakkai Zasshi; 2019; 116(10):773-779. PubMed ID: 31597875
    [No Abstract]   [Full Text] [Related]  

  • 62. Case studies of antibiotic therapy in the management of functional gastrointestinal disorders.
    Pimentel M; Cattano C; Christie J; Loewe C; Mohan V
    Gastroenterol Hepatol (N Y); 2007 Jan; 3(1 Suppl 1):1-12. PubMed ID: 21960770
    [No Abstract]   [Full Text] [Related]  

  • 63. Preface - Functional gastrointestinal disorders.
    Hellström PM
    Best Pract Res Clin Gastroenterol; 2019; 40-41():101605. PubMed ID: 31594652
    [No Abstract]   [Full Text] [Related]  

  • 64. Current Approaches to the Functional Gastrointestinal Disorders.
    Filipović B; Forbes A; Tepeš B
    Gastroenterol Res Pract; 2017; 2017():4957154. PubMed ID: 28115931
    [No Abstract]   [Full Text] [Related]  

  • 65. Functional gastrointestinal disorders-Are some preventable?
    Hill ID
    J Pediatr; 2019 Sep; 212():2-3. PubMed ID: 31439160
    [No Abstract]   [Full Text] [Related]  

  • 66. Why Should We Contemplate on Gender Difference in Functional Gastrointestinal Disorders?
    Jahng J; Kim YS
    J Neurogastroenterol Motil; 2017 Jan; 23(1):1-2. PubMed ID: 28049860
    [No Abstract]   [Full Text] [Related]  

  • 67. Changing Paradigms in Functional Gastrointestinal Disorders.
    Talley NJ
    Gastroenterol Hepatol (N Y); 2021 Sep; 17(9):427-430. PubMed ID: 34602907
    [No Abstract]   [Full Text] [Related]  

  • 68. How should We Classify and Treat Patients with Functional Gastrointestinal Disorders?
    McLaughlin JT
    Therap Adv Gastroenterol; 2008 Nov; 1(3):153-6. PubMed ID: 21180524
    [No Abstract]   [Full Text] [Related]  

  • 69. Comment on: current status of functional gastrointestinal evaluation in clinical practice.
    Wong MT; Tang CL
    Singapore Med J; 2015 Mar; 56(3):176. PubMed ID: 25820850
    [No Abstract]   [Full Text] [Related]  

  • 70. An In Vitro and In Silico Characterization of
    Randjelović M; Branković S; Jovanović M; Kitić N; Živanović S; Mihajilov-Krstev T; Miladinović B; Milutinović M; Kitić D
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242618
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peripheral CRF-R1/CRF-R2 antagonist, astressin C, induces a long-lasting blockade of acute stress-related visceral pain in male and female rats.
    Larauche M; Erchegyi J; Miller C; Sim MS; Rivier J; Behan D; Taché Y
    Peptides; 2022 Nov; 157():170881. PubMed ID: 36185037
    [TBL] [Abstract][Full Text] [Related]  

  • 72. COVID-19 Outbreak and its Burden on a New Wave of Functional Gastrointestinal Disorders.
    Nozari N
    Middle East J Dig Dis; 2021 Apr; 13(2):91-94. PubMed ID: 34712445
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of clinical symptoms after
    Azadbakht S; Azadbakht S; Esmaili A; Rahmani P
    New Microbes New Infect; 2020 Nov; 38():100806. PubMed ID: 33365132
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Correlation between lifestyle and social factors in functional dyspepsia among college freshmen.
    Huang ZP; Wang K; Duan YH; Yang G
    J Int Med Res; 2020 Aug; 48(8):300060520939702. PubMed ID: 32862752
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches.
    Holtmann G; Schrenk D; Madisch A; Allescher HD; Ulrich-Merzenich G; Mearin F; Larrey D; Malfertheiner P
    Dig Dis; 2020; 38(4):269-279. PubMed ID: 31770769
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.
    Tack J; Stanghellini V; Mearin F; Yiannakou Y; Layer P; Coffin B; Simren M; Mackinnon J; Wiseman G; Marciniak A;
    BMC Gastroenterol; 2019 May; 19(1):69. PubMed ID: 31064345
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correlation between social factors and anxiety-depression in function dyspepsia: do relationships exist?
    Huang ZP; Yang XF; Lan LS; Liu T; Liu CL; Li JL; Liang ZH
    Prz Gastroenterol; 2014; 9(6):348-53. PubMed ID: 25653730
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
    Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
    World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Functional disorders of the gastrointestinal tract: Cost effectiveness review.
    Mapel DW
    Best Pract Res Clin Gastroenterol; 2013 Dec; 27(6):913-31. PubMed ID: 24182611
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Rome III classification of functional gastrointestinal disorders in children with chronic abdominal pain].
    Plocek A; Wasowska-Królikowska K; Toporowska-Kowalska E
    Med Wieku Rozwoj; 2010; 14(4):350-6. PubMed ID: 21462479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.